TheraRadar
← Back
Data updated: Jun 28, 2026

ALEMBIC PHARMS LTD

Generics

ALEMBIC PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Respiratory. Key products include DESVENLAFAXINE.

2009
Since
21
Drugs
-
Trials
1
New Drugs (2yr)

ALEMBIC PHARMS LTD's Key Drugs

ALEMBIC PHARMS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ALEMBIC PHARMS LTD's Therapeutic Areas

ALEMBIC PHARMS LTD's approved drugs and pipeline span 4 therapeutic areas, led by Cardiovascular and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Cardiovascular 50%
4 drugs
Neurology 25%
2 drugs
Respiratory 13%
1 drugs
Gastroenterology 13%
1 drugs

ALEMBIC PHARMS LTD's Top Competitors

ALEMBIC PHARMS LTD's closest competitors by therapeutic-area and drug-target overlap include GE HEALTHCARE, CHIESI, and ACTELION. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

ALEMBIC PHARMS LTD Pipeline Snapshot

Active clinical trials for ALEMBIC PHARMS LTD across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Cardiovascular pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling